Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback